Navigation Links
IPC The Hospitalist Company Completes New Jersey Acquisition
Date:9/2/2009

NORTH HOLLYWOOD, Calif., Sept. 2 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice company, announced today that it has acquired Hospital Medicine Associates, P.C. (HMA). Based in Livingston, New Jersey, HMA represents IPC's second practice group in the state, following the recent acquisition of a hospitalist group in nearby Morristown. IPC expects to add approximately 25,000 patient encounters annually from the HMA acquisition.

Adam Singer, M.D., IPC's Chairman and CEO, said, "IPC initially established operations in New Jersey in June of this year and the acquisition of HMA will serve to strengthen our presence in this important market. HMA is a high-quality group of providers with skilled leadership but faced the challenges of a limited business infrastructure. Now HMA can build on our solid business platform to grow its practice and reach its full potential."

Ed Crandell, IPC's Executive Director for the region, commented, "HMA's hospitalists will continue to practice at St. Barnabas Medical Center and also provide coverage at skilled nursing and rehabilitation facilities in the surrounding area. We believe that the additional resources from IPC in areas such as recruitment, technology and quality initiatives will enable HMA to increase service levels in these facilities as well as provide opportunities for expansion to additional sites."

HMA's owner, Jaqueline Holubka M.D., will remain with the group and continue to serve as Practice Group Leader. Dr. Holubka remarked, "I look forward to continuing my career as a hospitalist with the IPC family. I've been very impressed with the quality of IPC's clinical leadership and with the company's constant attention to innovation and support of its practice groups."

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com.

    Media Contact:                       Investor Contacts:
    Scott Public Relations               The Ruth Group
    Elaine Murphy                        Amy Glynn/Nick Laudico
    818.610.0270                         646.536.7023/7030
    elaine@scottpublicrelations.com      aglynn@theruthgroup.com
                                         nlaudico@theruthgroup.com


'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IPC The Hospitalist Company Reports Second Quarter 2009 Results
2. IPC The Hospitalist Company Acquires Tampa Practice
3. Locum Leaders Taps Hospitalist as Chief Medical Officer; Strengthens Leadership in Hospital Medicine Recruitment and Job Placement
4. IPC The Hospitalist Company, Inc. to Report Second Quarter 2009 Results
5. IPC The Hospitalist Company Expands Coverage in Tucson
6. IPC The Hospitalist Company Inc. CEO, Adam Singer, M.D., Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in the Greater Los Angeles Area
7. IPC The Hospitalist Company Expands Into New Jersey
8. IPC The Hospitalist Company, Inc. to Present at Jefferies 3rd Annual Healthcare Conference
9. Availability of diagnostic tests drive success in hospitalist-run short-stay units
10. IPC The Hospitalist Company, Inc. to Present at Citis 2009 Healthcare Services Day
11. IPC The Hospitalist Company CEO Adam Singer Named One of 50 Most Powerful Physician Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... ... 2016 , ... A newly released study has found that ... accuracy of placing precordial electrodes with little cognitive effort and a high degree ... studies have shown that single electrode misplacement is one of the single largest ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec 5, 2016 Research and Markets ... Market - Global Forecast to 2021" report to their offering. ... , , ... reach 17.27 billion by 2021, at a CAGR of 5.3% from 2016 ... growing number of obesity cases, increasing government spending on healthcare, and rising ...
(Date:12/5/2016)... PharmaBoardroom today releases its new 70 page Switzerland Healthcare & Life ... , , ... stakeholders crucial insight into Switzerland ; a country located ... of the world,s most important international health institutions as well as two ... number one ranking globally in terms of ease of doing business and ...
(Date:12/4/2016)... , Dec. 4, 2016 Blueprint ... in discovering and developing targeted kinase medicines for ... from its ongoing Phase 1 trial evaluating BLU-285, ... with advanced systemic mastocytosis (SM). Blueprint Medicines is ... of D816V mutant KIT. Approximately 90 to 95 ...
Breaking Medicine Technology: